← Back to Search

CLASP for Suicide Prevention (3C Trial)

N/A
Recruiting
Led By Lauren Weinstock, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after discharge
Awards & highlights

3C Trial Summary

This trial will study whether the Coping Long Term with Active Suicide Program (CLASP) can help reduce suicide risk in veterans.

Who is the study for?
The Veterans Coordinated Community Care (3C) Study is for veterans at least 18 years old who are considered high-risk for suicide after leaving the hospital. They must be able to speak English, make their own decisions, and have access to a phone post-discharge.Check my eligibility
What is being tested?
This study tests if adding the Coping Long Term with Active Suicide Program (CLASP) to usual treatment helps reduce suicide-related behaviors in veterans. Participants will either receive standard care or standard plus CLASP and will be monitored for six months.See study design
What are the potential side effects?
Since this trial involves a psychological support program rather than medication, typical medical side effects are not expected. However, discussing sensitive topics may cause emotional discomfort.

3C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

3C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
3C Suicide Outcome Measure
Veterans Affairs Healthcare System (VAHS) health and administrative records on suicide related behaviors
Secondary outcome measures
3C Suicidal Ideation and Functioning Outcome Measure
Veterans Affairs Healthcare System (VAHS) health and administrative records on suicidal ideation and functioning

3C Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Coping Long Term with Active Suicide Program (CLASP)Experimental Treatment1 Intervention
The CLASP intervention is an adjunctive, telehealth-based behavioral intervention designed to reduce suicidal behavior among individuals at high risk for suicide going through periods of transition. CLASP is designed to intervene on four risk factor targets: ongoing treatment engagement, problem-solving, social and family support, and hopelessness. In addition to these general factors, the CLASP provider also has the flexibility to identify and target certain "patient-specific" risk factors (e.g., substance misuse) for intervention. CLASP will begin after completion of the baseline assessment, and will continue for 6 months post-discharge. CLASP will be comprised of: a) 3 initial sessions while participants are still inpatients (can occur post-discharge if needed); b) 12 brief telehealth sessions over 6-months post-discharge; c) 6 brief SO telehealth sessions.
Group II: Treatment As Usual (TAU)Active Control1 Intervention
Treatment As Usual (TAU) consists of unrestricted treatment provided as part of routine care in the Veterans Health Administration (VHA) following inpatient hospitalization. Study staff will provide no additional treatment in this arm.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for suicide, such as those similar to the Coping Long Term with Active Suicide Program (CLASP), include cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT). These therapies work by helping patients identify and change negative thought patterns, develop problem-solving skills, and build emotional regulation abilities. They also incorporate social support and crisis planning, which are essential for reducing feelings of isolation and providing immediate coping mechanisms during suicidal crises. These mechanisms are crucial for suicide patients as they address the underlying cognitive and emotional factors contributing to suicidal ideation, thereby reducing the risk of suicide attempts.
A treatment strategy for meeting life as it is. Patients' and therapists' experiences of brief therapy in a district psychiatric centre: A qualitative study.Effectiveness of a Suicide Prevention Module for Adults in Substance Use Disorder Treatment: A Stepped-Wedge Cluster-Randomized Clinical Trial.Reports on the Perceived Advantages and Disadvantages of Suicidal Behavior by Patients With Depression.

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
456 Previous Clinical Trials
557,406 Total Patients Enrolled
12 Trials studying Suicide
3,078 Patients Enrolled for Suicide
Harvard UniversityOTHER
230 Previous Clinical Trials
473,755 Total Patients Enrolled
7 Trials studying Suicide
81,080 Patients Enrolled for Suicide
Canandaigua VA Medical CenterFED
12 Previous Clinical Trials
996 Total Patients Enrolled
2 Trials studying Suicide
357 Patients Enrolled for Suicide

Media Library

Suicide Research Study Groups: Coping Long Term with Active Suicide Program (CLASP), Treatment As Usual (TAU)
~255 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top